03.02.2019, 2516 Zeichen

FACC: Austrian based FACC, leading aerospace company in design, development and production of innovative aircraft components and systems, has reached another milestone in the implementation of its interior strategy: For the solution developed by FACC to significantly increase the luggage stowage space, the European Aviation Safety Agency (EASA) has issued a Supplemental Type Certification (STC) to FACC for the "Passenger Luggage Space Upgrade" to be installed in the A320 aircraft family. At the same time, FACC also extended the scope of work as a design organization (DOA) with STC projects and major repairs. Within its new Aftermarket Services business segment, these approvals will provide FACC with further opportunities to benefit from growth in the global retrofit market.
FACC: weekly performance: -0.62%

OMV: Austrian oil and gas company OMV and Sapura Energy Berhad have closed the agreement to form a strategic partnership. OMV Exploration & Production GmbH, a wholly-owned subsidiary of OMV Aktiengesellschaft, has bought a 50% stake of the issued share capital in a new joint venture company, which will be called SapuraOMV Upstream Sdn. Bhd.  OMV paid USD 540 mn for its 50% interest in SapuraOMV Upstream Sdn. Bhd. In addition, the parties agreed to an additional consideration of up to USD 85 mn based on certain conditions, mainly linked to the resource volume in Block 30, Mexico, at the time the final investment decision is taken. Both parties have also agreed to refinance the existing inter-company debt of USD 350 mn. SapuraOMV Upstream Sdn. Bhd is a major independent oil and gas company based in Malaysia with an expected life of field production of approximately 260 mn boe and strong growth prospects.
OMV: weekly performance: 0.92%

Marinomed: With the successful initial public offering (IPO), the shares of Marinomed Biotech AG started trading in the top segment of the Vienna Stock Exchange on Friday, February 1st. The IPO of Marinomed Biotech AG is the first in Europe this year. Market supply and demand determined the first stock market price of Euro 75.5. The market capitalisation of the globally-active Vienna-based biopharmaceutical company computed on the opening price was Euro 95.13 mn (excl. greenshoe). On the second day of trading, Monday, 4 February 2019, Marinomed Biotech AG will be added to the indices "ATX prime" and "ATX global players".
Marinomed Biotech: weekly performance: 0.00%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (01/02/2019)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #856: ATX TR 10.000, wie wärs mir einer PK? Wir haben O-Töne zum Rekord und Palfinger erwähnt Rheinmetall

Bildnachweis

Aktien auf dem Radar:Strabag, Frequentis, Porr, EuroTeleSites AG, Pierer Mobility, Agrana, OMV, Semperit, CA Immo, Immofinanz, Verbund, Andritz, AT&S, Bawag, BTV AG, Erste Group, Gurktaler AG VZ, Lenzing, Palfinger, Österreichische Post, voestalpine, Wienerberger, Wolford, Zumtobel, BKS Bank Stamm, Oberbank AG Stamm, Austriacard Holdings AG, Amag, EVN, Flughafen Wien, Telekom Austria.

---